Evaluating the 1-year success and safety of ab interno canaloplasty in combination with cataract surgery in glaucoma patients.

IF 1.4 4区医学 Q3 OPHTHALMOLOGY International Ophthalmology Pub Date : 2024-10-14 DOI:10.1007/s10792-024-03325-0

Lina Nassri, Julia Prinz, Hannah Schellhase, Matthias Fuest, Antonis Koutsonas, Niklas Plange, David Kuerten

{"title":"Evaluating the 1-year success and safety of ab interno canaloplasty in combination with cataract surgery in glaucoma patients.","authors":"Lina Nassri, Julia Prinz, Hannah Schellhase, Matthias Fuest, Antonis Koutsonas, Niklas Plange, David Kuerten","doi":"10.1007/s10792-024-03325-0","DOIUrl":null,"url":null,"abstract":"Purpose: To evaluate the treatment success and safety of ab interno canaloplasty (AbiC) combined with cataract surgery in glaucoma patients.Methods: The prospective case study included 43 eyes that received an AbiC combined with cataract surgery (age 73.3 ± 8.2 years). The 360° microcatheterization and viscodilatation of the Schlemm's canal was conducted using VISCO 360 (Sight Sciences, CA, USA). The observation period was 12 months with visits at 2 and 6 as well as 12 months, 7 eyes were lost to follow up.Results: The preoperative IOP was 19.8 ± 4.9 mmHg and was reduced to 14.5 ± 2.8 mmHg 12 months after AbiC (p < 0.0001). The relative IOP reduction was 23.6 ± 23.1% after 12 months. Topical glaucoma medication was also reduced from 2.4 ± 1.1 drugs to 1.1 ± 1.4 (p < 0.001) after 12 months. The complete surgical success rate (defined as IOP < 18 mmHg without topical therapy) was 31.6% whereas the qualified surgical success was 89.5% (IOP < 18 mmHg, with local therapy) There were no relevant intra- or postoperative complications.Conclusion: AbiC in combination with cataract surgery is a safe and effective procedure to achieve a significant reduction of IOP and local glaucoma medication 12 months after surgery.","PeriodicalId":14473,"journal":{"name":"International Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11473546/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10792-024-03325-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To evaluate the treatment success and safety of ab interno canaloplasty (AbiC) combined with cataract surgery in glaucoma patients.

Methods: The prospective case study included 43 eyes that received an AbiC combined with cataract surgery (age 73.3 ± 8.2 years). The 360° microcatheterization and viscodilatation of the Schlemm's canal was conducted using VISCO 360 (Sight Sciences, CA, USA). The observation period was 12 months with visits at 2 and 6 as well as 12 months, 7 eyes were lost to follow up.

Results: The preoperative IOP was 19.8 ± 4.9 mmHg and was reduced to 14.5 ± 2.8 mmHg 12 months after AbiC (p < 0.0001). The relative IOP reduction was 23.6 ± 23.1% after 12 months. Topical glaucoma medication was also reduced from 2.4 ± 1.1 drugs to 1.1 ± 1.4 (p < 0.001) after 12 months. The complete surgical success rate (defined as IOP < 18 mmHg without topical therapy) was 31.6% whereas the qualified surgical success was 89.5% (IOP < 18 mmHg, with local therapy) There were no relevant intra- or postoperative complications.

Conclusion: AbiC in combination with cataract surgery is a safe and effective procedure to achieve a significant reduction of IOP and local glaucoma medication 12 months after surgery.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

评估青光眼患者在进行白内障手术的同时进行人工晶体植入术的 1 年成功率和安全性。

目的：评估青光眼患者瞳孔内人工晶体植入术（AbiC）联合白内障手术的治疗成功率和安全性：前瞻性病例研究包括 43 只接受 AbiC 联合白内障手术的眼睛（年龄 73.3 ± 8.2 岁）。使用 VISCO 360（Sight Sciences，加利福尼亚州，美国）对施莱姆管进行 360° 微导管和粘度扩张。观察期为 12 个月，分别在术后 2 个月、6 个月和 12 个月进行随访，有 7 只眼睛失去了随访机会：结果：术前眼压为 19.8 ± 4.9 mmHg，AbiC 术后 12 个月降至 14.5 ± 2.8 mmHg（PAbiC与白内障手术相结合是一种安全有效的手术，可在术后12个月显著降低眼压并减少局部青光眼用药。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International Ophthalmology OPHTHALMOLOGY-

CiteScore

3.20

自引率

0.00%

发文量

451

期刊介绍： International Ophthalmology provides the clinician with articles on all the relevant subspecialties of ophthalmology, with a broad international scope. The emphasis is on presentation of the latest clinical research in the field. In addition, the journal includes regular sections devoted to new developments in technologies, products, and techniques.